PR Newswire Clinical TrialsOriginal article
BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin
Northstar OriginNorthstar SelectPositive
AI Analysis
Summary
BillionToOne launched Northstar Origin, a new liquid biopsy test for identifying tissue of origin from a single blood draw, and expanded its Northstar Select panel to 102 genes.
Importance:4/10
Sentiment:
0.60
liquid biopsydiagnosticsproduct launchmolecular testing
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 1, 2026 1:00 PM